Patients' and Providers' Perspectives of a Dose Administration Aid Strategy to Improve Cardiovascular Disease prevention in Australian Primary Healthcare

Overview

Journal BMC Health Serv Res

Publisher Biomed Central

Specialty Health Services

Date 2025 Feb 21

PMID 39984999

Authors

Kanika Chaudhri

Hueiming Liu

Anthony Rodgers

Richard Day

Emily R Atkins

Sonali R Gnanenthiran

Affiliations

Soon will be listed here.

Abstract

Background: Hypertension is the most commonly managed problem in general practice in Australia, but blood pressure control is not achieved for most patients. An important factor to consider in hypertension control is patient medication adherence. Use of dose administration aids (DAAs) could increase adherence to medicines and reduce the frequency of medication errors. We conducted a trial to evaluate adherence to DAAs in real-world conditions. This study is a process evaluation of the main trial. This stydy aims to understand the acceptability of DAAs from patients, providers, and carers perspectives and examine implementation barriers and facilitators of trial processes.

Methods: In-depth, semi structured interviews were conducted in an Australian general practice participating in a pilot randomised controlled trial evaluating a DAA-based strategy for people with high-risk primary and secondary cardiovascular disease. Interview topics included DAA acceptability, factors affecting adherence and trial implementation. Transcribed interview data were analysed thematically and interpretively. The consolidated framework for implementation research was used to guide our analysis.

Results: Nineteen interviews were conducted (16 participants or carers, 1 physician, 1 pharmacist and 1 DAA packaging company representative). All trial participants reported improved adherence, especially in those with prior poor adherence. Key barriers to DAA use included inertia to change, resistance from the pharmacist with regards to repackaging by an external provider, logistics of direct home delivery and lack of communication. A key facilitator to trial implementation was the therapeutic relationship of patients with the health care professionals.

Conclusion: The DAA strategy was generally acceptable to patients and the physician as a cardiovascular preventative strategy. Participants suggested a DAA-based strategy as particularly appropriate for those with prior poor adherence to medications.

Trial Registration: ACTRN12620001239954. 19/11/2020.

References

Chaudhri K, Kearney M, Di Tanna G, Day R, Rodgers A, Atkins E . Does splitting a tablet obtain the accurate dose?: A systematic review protocol. Medicine (Baltimore). 2019; 98(42):e17189. PMC: 6824647. DOI: 10.1097/MD.0000000000017189. View

Al-Noumani H, Wu J, Barksdale D, Sherwood G, AlKhasawneh E, Knafl G . Health beliefs and medication adherence in patients with hypertension: A systematic review of quantitative studies. Patient Educ Couns. 2019; 102(6):1045-1056. DOI: 10.1016/j.pec.2019.02.022. View

Orton L, Barnish G . Unit-dose packaged drugs for treating malaria. Cochrane Database Syst Rev. 2005; (2):CD004614. PMC: 6532754. DOI: 10.1002/14651858.CD004614.pub2. View

Chaudhri K, Caleres G, Saunders S, Michail P, Di Tanna G, Lung T . Does Collaboration between General Practitioners and Pharmacists Improve Risk Factors for Cardiovascular Disease and Diabetes? A Systematic Review and Meta-Analysis. Glob Heart. 2023; 18(1):7. PMC: 9951619. DOI: 10.5334/gh.1184. View

Chesney M, Ickovics J, Chambers D, Gifford A, Neidig J, Zwickl B . Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group.... AIDS Care. 2000; 12(3):255-66. DOI: 10.1080/09540120050042891. View

Gomes M, Wayling S, Pang L . Interventions to improve the use of antimalarials in south-east Asia: an overview. Bull World Health Organ. 1998; 76 Suppl 1:9-19. PMC: 2305573. View

Degli Esposti L, Degli Esposti E, Valpiani G, Di Martino M, Saragoni S, Buda S . A retrospective, population-based analysis of persistence with antihypertensive drug therapy in primary care practice in Italy. Clin Ther. 2002; 24(8):1347-57; discussion 1346. DOI: 10.1016/s0149-2918(02)80039-x. View

Jones J, Gorkin L, Lian J, Staffa J, Fletcher A . Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population. BMJ. 1995; 311(7000):293-5. PMC: 2550362. DOI: 10.1136/bmj.311.7000.293. View

Moore G, Audrey S, Barker M, Bond L, Bonell C, Hardeman W . Process evaluation of complex interventions: Medical Research Council guidance. BMJ. 2015; 350:h1258. PMC: 4366184. DOI: 10.1136/bmj.h1258. View

10.

Damschroder L, Aron D, Keith R, Kirsh S, Alexander J, Lowery J . Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009; 4:50. PMC: 2736161. DOI: 10.1186/1748-5908-4-50. View

11.

Gaglio B, Phillips S, Heurtin-Roberts S, Sanchez M, Glasgow R . How pragmatic is it? Lessons learned using PRECIS and RE-AIM for determining pragmatic characteristics of research. Implement Sci. 2014; 9:96. PMC: 4243945. DOI: 10.1186/s13012-014-0096-x. View

12.

Lauer M, DAgostino Sr R . The randomized registry trial--the next disruptive technology in clinical research?. N Engl J Med. 2013; 369(17):1579-81. DOI: 10.1056/NEJMp1310102. View

13.

van der Laan D, Elders P, Boons C, Beckeringh J, Nijpels G, Hugtenburg J . Factors associated with antihypertensive medication non-adherence: a systematic review. J Hum Hypertens. 2017; 31(11):687-694. DOI: 10.1038/jhh.2017.48. View

14.

Atkins L, Fallowfield L . Intentional and non-intentional non-adherence to medication amongst breast cancer patients. Eur J Cancer. 2006; 42(14):2271-6. DOI: 10.1016/j.ejca.2006.03.004. View

15.

Wiseman L . Calendar (blister) packs for multiple drug therapy in leprosy: an inexpensive, locally-produced version. Lepr Rev. 1987; 58(1):85-7. View

16.

Tong A, Sainsbury P, Craig J . Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007; 19(6):349-57. DOI: 10.1093/intqhc/mzm042. View

17.

Unni E, Farris K . Unintentional non-adherence and belief in medicines in older adults. Patient Educ Couns. 2010; 83(2):265-8. DOI: 10.1016/j.pec.2010.05.006. View

18.

Relton C, Torgerson D, OCathain A, Nicholl J . Rethinking pragmatic randomised controlled trials: introducing the "cohort multiple randomised controlled trial" design. BMJ. 2010; 340:c1066. DOI: 10.1136/bmj.c1066. View

19.

Leslie K, McCowan C, Pell J . Adherence to cardiovascular medication: a review of systematic reviews. J Public Health (Oxf). 2018; 41(1):e84-e94. PMC: 6459362. DOI: 10.1093/pubmed/fdy088. View

20.

Skivington K, Matthews L, Simpson S, Craig P, Baird J, Blazeby J . A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance. BMJ. 2021; 374:n2061. PMC: 8482308. DOI: 10.1136/bmj.n2061. View